MD ANDERSON CANCER CENTER and AbbVie formed a three-year collaboration to perform preclinical and clinical studies evaluating immuno-oncology therapies. AbbVie and MD Anderson will each assign two scientists to a joint scientific committee, which will decide on which projects to pursue. The collaboration will begin with projects driven by AbbVie Biotherapeutics. Future projects will draw...
At a time when federal immigration policies are becoming stricter, Kunle Odunsi, director of University of Chicago Medicine Comprehensive Cancer Center, reflected on the fact that cancer research is a highly international community.
